Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset
Objective Intravenous tissue plasminogen activator (tPA) is the standard therapy for patients with acute ischaemic stroke (AIS) within 4.5 hours of onset. Recent trials have expanded the endovascular treatment window to 24 hours. We investigated the efficacy and safety of using multimodal MRI to gui...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-03-01
|
Series: | Stroke and Vascular Neurology |
Online Access: | https://svn.bmj.com/content/4/1/3.full |